This Trial is Conducted in Europe. The Aim of This Trial is to Investigate Pharmacodynamics (the Effect of the Investigated Drug on the Body) , Pharmacokinetics (the Exposure of the Trial Drug in the Body), and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus.

Trial Profile

This Trial is Conducted in Europe. The Aim of This Trial is to Investigate Pharmacodynamics (the Effect of the Investigated Drug on the Body) , Pharmacokinetics (the Exposure of the Trial Drug in the Body), and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Aug 2017

At a glance

  • Drugs NN 1406 (Primary) ; Insulin aspart
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 18 Aug 2017 Status changed from active, no longer recruiting to completed.
    • 24 May 2017 Status changed from recruiting to active, no longer recruiting.
    • 22 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top